Adverse drug events associated with capecitabine: a real-world pharmacovigilance study based on the FAERS database
Background: Capecitabine, a prodrug of 5-fluorouracil, is extensively utilized for the treatment of metastatic breast cancer, colorectal cancer, and gastric cancer. Nevertheless, there exist limitations in comprehending adverse reactions (AEs) in clinical practice. In this study, we investigated the...
Saved in:
| Main Authors: | Rongqiang Liu, Yukai Chen, Shi-Nan Wu, Wangbin Ma, Zhendong Qiu, Jianguo Wang, Ximing Xu, Chen Chen, Weixing Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2024-12-01
|
| Series: | Therapeutic Advances in Drug Safety |
| Online Access: | https://doi.org/10.1177/20420986241303428 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A real-world pharmacovigilance analysis of omadacycline in FDA adverse event reporting system (FAERS) database
by: Xueping Shi, et al.
Published: (2025-04-01) -
Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database
by: Bingqing Wang, et al.
Published: (2025-05-01) -
Adverse event profiles of selpercatinib: a real-world pharmacovigilance analysis based on FAERS database
by: Jiancheng Qian, et al.
Published: (2024-12-01) -
Thrombotic adverse events associated with TNF-alpha blockers: a real-world pharmacovigilance analysis of the FAERS database
by: Lijuan Song, et al.
Published: (2025-04-01) -
Postmarketing adverse events of efgartigimod alfa: a real-world pharmacovigilance study based on the FAERS database
by: Yaxin Ju, et al.
Published: (2025-07-01)